Stock Based Compensation (Details) - Stock Options [Member] - USD ($) |
3 Months Ended | |
|---|---|---|
Jun. 30, 2019 |
Mar. 31, 2019 |
|
| Number of Shares | ||
| Beginning Balance | 8,526,510 | 9,161,510 |
| Grants | 4,600,000 | |
| Expirations | (563,184) | (635,000) |
| Ending Balance | 12,563,326 | 8,526,510 |
| Options exercisable | 12,563,326 | |
| Weighted Average Exercise Price | ||
| Beginning Balance | $ 1.19 | $ 1.15 |
| Expirations | 11.19 | |
| Grants | 0.27 | |
| Ending Balance | 0.55 | $ 1.19 |
| Options exercisable | $ 0.55 | |
| Weighted Average Remaining Contractual Life (years) | ||
| Weighted Average Remaining Contractual Life (years), beginning | 2 years | |
| Weighted Average Remaining Contractual Life (years), grants | 5 years | |
| Weighted Average Remaining Contractual Life (years), ending | 4 years 6 months | 1 year 10 months 25 days |
| Options exercisable | 4 years 6 months | |
| Aggregate Intrinsic Value | ||
| Beginning Balance | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|